Nuclear Medicine Market Set To Be Worth of $6.96 Billion by 2020

The nuclear medicine/radiopharmaceuticals market is segmented on the basis of type, application, and region.

Persone Rohan Unit, Health
Luoghi Italia, Europa, Africa, Medio Oriente, America del Nord, Canada, India, Germania, Francia, Irlanda, Pune, Stati Uniti d'America, Regno Unito, Maharashtra, Wé, Our
Organizzazioni Lantheus Medical Imaging Inc., Bracco Imaging S.p.A, Nuclear Medicine/Radiopharmaceuticals Market
Argomenti commercio, economia, software, internet

12/feb/2016 10.01.59 MarketsandMarkets Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.
The report “Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90), by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2020”, This market is expected to reach $6.96 Billion by 2020 at a CAGR of 9.1% during the forecast period.
 
Browse 113 market data tables and 55 figures spread through 230 pages and in-depth TOC on “Nuclear Medicine/Radiopharmaceuticals Market"
http://www.marketsandmarkets.com/Market-Reports/radiopharmaceuticals-market-417.html
Early buyers will receive 10% customization on this report.
 
The nuclear medicine/radiopharmaceuticals market is segmented on the basis of type, application, and region. The global nuclear medicine/radiopharmaceuticals market is valued at $4.50 billion in 2015 and is poised to grow at a CAGR of 9.1% during the forecasted period.
 
Get PDF Brochure For This Report:
http://www.marketsandmarkets.com/pdfdownload.asp?id=417
 
On the other hand, the therapeutics market is further segmented into beta emitters, alpha emitters, and brachytherapy isotopes. On the basis of applications, the nuclear medicine/radiopharmaceuticals market is segmented into diagnostics (SPECT and PET) and therapeutics applications. On the basis of regions, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW: Latin America, the Middle East, and Africa). In 2014, North America accounted for the largest share of the nuclear medicine market, followed by Asia-Pacific and Europe.
 
Factors such as advances in radiotracers, alpha radio immunotherapy-based targeted cancer treatment, and increasing number of patients with cancer and cardiovascular aliments are driving the growth of this market. Moreover, potential radioisotopes in the pipeline, high demand from emerging countries, and advances in neurological applications are likely to create huge opportunities for this market in the coming years. However, factors such as shorter half-life of radiopharmaceuticals, stringent regulatory guidelines, and competition from conventional diagnostic procedures are hindering the growth of this market.
 
Speak to Research Analyst: www.marketsandmarkets.com/speaktoanalyst.asp?id=417
 
Some of the major players in the nuclear medicine/radiopharmaceuticals market include Cardinal Health, Inc. (U.S.), GE Healthcare (U.K.), Bracco Imaging S.p.A (Italy), Eczacibasi-Monrol Nuclear Products (Turkey), Nordion, Inc. (Canada), Advanced Accelerator Applications S.A. (France), Bayer Healthcare (Germany), Lantheus Medical Imaging, Inc. (U.S.), IBA Molecular Imaging (Belgium), and Mallinckrodt plc (Ireland).
 
About MarketsandMarkets:
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
 
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
 
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
 
Contact:
Mr. Rohan

Unit No. 802, 8th Floor, 
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013, 
Maharashtra, India.
Tel: +1-888-6006-441.
 
Get your own FREE website, FREE domain & FREE mobile app with Company email.  
Know More >
blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl